The agency recently explained that it considers the bigger picture in determining when a drug should be on its shortage list, saying, FDA generally considers a shortage to be resolved based on an evaluation of the entire market, assessing whether all backorders have been filled and supply is meeting or exceeding demand. Could things be improving
Some are FDA-approved for managing type 2 diabetes (even though they aid with weight loss), and some, such as the brand Zepbound by Eli Lilly, are now specifically approved for weight loss
Viking Therapeutics (VKTX) released new clinical trial data early this week for its experimental weight-loss drugs, which include a highly anticipated oral pill
Who Should Consider This Combination, and Important Safety Guardrails Combination therapy may be appropriate for patients with documented suboptimal weight loss on semaglutide monotherapy, adequate GI tolerance, and provider-confirmed medical necessity
appearance, Kennedy Jr